Home Creyon Bio

Creyon Bio

In operation
Series A
RNA Drug Developer
Basic
Enterprise Profile

Basic Information

Creyon Bio, led by co-founder, CEO and President Chris Hart and co-founder and Chief Scientific Officer Dr. Swagatam Mukhopadhyay, is a drug development company focused on developing RNA-based therapeutics and their components. Creyon Bio creates proprietary, purpose-built datasets to inform machine learning models, rapidly identifying design rules and engineering principles for safe and effective OBM.
Creyon Bio
SanDiego,California,United States of America
unclear
January 01, 2019
info@creyonbio.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products CXO (Pharmaceutical Outsourcing Organization)
Technology
Machine Learning
Concept
Therapeutic Products Department of Pharmacy
Application Scenarios
Biologics Innovative Drugs AI+Pharmaceuticals